ArticleGenetic epidemiology2025
Exploring Random Forest in Genetic Risk Score Construction.
Article in Genetic epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development of a machine learning model for preoperative prediction of spread through air spaces in resectable non-small cell lung cancer: A single-center retrospective study.Oncology letters · 2026Article
- Exploring Random Forest in Genetic Risk Score Construction.Genetic epidemiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Genetic risk scores (GRS) are crucial tools for estimating an individual's genetic liability to various traits and diseases, computed as a weighted sum of trait-associated allele counts. Traditionally, GRS models assume additive, linear effects of risk variants. However, complex traits often involve nonadditive interactions, such as epistasis, which are not captured by these conventional methods. In this study, we investigate the use of random forest (RF) models as a model-free approach for constructing GRS, leveraging RF's capacity to capture complex, nonlinear interactions among genetic variants. Specifically, we introduce two new RF-based GRS strategies to boost RF performance and to incorporate base data information if available, including (1) ctRF, which optimizes linkage disequilibrium (LD) clumping and p-value thresholds within RF; and (2) wRF, which adjusts the chance of SNP inclusion in tree nodes based on their association strength. Through simulation studies and real data applications of Alzheimer's disease, body mass index, and atopy, we find that ctRF consistently outperforms other RF-based methods and classical additive models when traits exhibit complex genetic architectures. Additionally, incorporating informative base data into RF-GRS construction can enhance predictive accuracy. Our findings suggest that RF-based GRS can effectively capture intricate genetic interactions, and offer a robust alternative to traditional GRS methods, especially for complex traits with nonlinear genetic effects.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.